Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 19, 2026
TickeronGET DAILY SIGNALS
NSEP: Innovator's Defined-Outcome ETF Targets Nasdaq-100 Growth with Built-In Buffer

NSEP: Innovator's Defined-Outcome ETF Targets Nasdaq-100 Growth with Built-In Buffer

Key Takeaways

  • NSEP is a defined-outcome ETF that seeks to track the return of the Invesco QQQ Trust (QQQ) up to a cap while buffering the first 15% of losses over a one-year outcome period.
  • The fund is issued by Innovator Capital Management and launched in August 2024, resetting its outcome period approximately every September.
  • NSEP uses FLEX options rather than directly holding the Nasdaq-100's underlying stocks, giving it a portfolio of a few option positions plus cash collateral.
  • The fund is actively managed and non-diversified, with a net expense ratio of 0.79%.
  • NSEP is designed for investors seeking downside protection on large-cap growth exposure in exchange for capped upside.

What Is NSEP?

NSEP stands for the Innovator Growth-100 Power Buffer ETF – September. It falls into the defined-outcome category of ETFs, which use options strategies to deliver exposure to an underlying index with built-in buffers and caps. In this case, the fund aims to follow the price return of the Invesco QQQ Trust (QQQ) up to a preset cap while protecting against the first 15% of losses during each annual outcome period. I find this structure particularly relevant for investors who want large-cap growth exposure but prefer to limit some of the downside volatility that often comes with technology-heavy benchmarks.

ETFs like this trade on exchanges just like individual stocks, providing a single security that bundles the strategy. NSEP appeals to those looking for Nasdaq-100 participation without full market swings, especially if they are willing to trade some upside potential for that protection layer.

Investment Strategy and Outcome Period

The core objective is to match QQQ's price return up to a cap while buffering the initial 15% of losses before fees and expenses. Each outcome period lasts about one year and resets around September. Holding through the full period delivers the intended buffer and cap, though mid-period purchases or sales can alter the effective levels.

Innovator Capital Management actively manages the fund using FLEX options on QQQ combined with cash and short-term collateral. This options-based approach means the fund forgoes dividend income from the underlying index, which sets it apart from directly owning QQQ or a standard Nasdaq-100 fund. When analyzing comparable strategies, I sometimes cross-reference details with Tickeron’s AI Screener to compare buffer levels across similar products.

Portfolio Structure and Sector Exposure

Holdings stay concentrated, typically consisting of a handful of FLEX option positions on QQQ plus cash collateral. Effective exposure tracks the Nasdaq-100, with notable weight in technology and communication services alongside consumer, healthcare, and industrial names. This options-driven profile means performance depends more on option pricing, the reset levels, and the distance to the cap or buffer than on individual stock dividends or earnings.

The fund operates as non-diversified with a 0.79% net expense ratio, which aligns with the active management required for these strategies. One thing that stands out is how this setup creates a different risk-return profile from traditional index ETFs.

Who Might Find NSEP Useful?

Investors often turn to NSEP when they want continued exposure to large-cap growth names while gaining some cushion against declines. The 15% buffer can suit risk-conscious portfolios, including those of retirees or investors with nearer-term horizons. In my view, it serves as a potential partial replacement for a straight QQQ allocation in certain market environments, offering a smoother path during downturns.

From a broader perspective, the annual reset provides a clear framework for planning around technology sector trends. I’m watching this closely as part of how defined-outcome products fit into diversified equity sleeves.

Key Risks and Trade-Offs

The primary limitation is the upside cap: strong QQQ rallies mean shareholders miss gains above the preset level. The buffer covers only the first 15% of losses, so larger declines pass through to investors. These features apply fully only for those holding the entire outcome period.

Additional considerations include option implementation risks, potential tracking differences versus QQQ, the lack of dividends, and the higher expense ratio relative to plain index funds. As a non-diversified vehicle, it can also behave differently in stressed markets.

Using AI Tools in ETF Analysis

When evaluating defined-outcome ETFs like NSEP, I often turn to Tickeron’s AI Screener to quickly filter for similar strategies based on volatility, sector exposure, and outcome parameters. It helps surface comparable funds and refine ideas without manually sorting through dozens of options. This kind of tool supports a more efficient research process when building or adjusting portfolio allocations around buffered equity exposure.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NSEP

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


NSEP in downward trend: price dove below 50-day moving average on October 29, 2026

NSEP moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend. In 10 of 11 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NSEP as a result. In 17 of 36 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 47%.

The 10-day moving average for NSEP crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSEP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 37%.

The Aroon Indicator for NSEP entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NSEP's RSI Indicator exited the oversold zone, 4 of 5 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +2.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where NSEP advanced for three days, in 125 of 164 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

NSEP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks to provide investors with returns that match the return of the Underlying ETF, up to the upside cap of 18.57% while providing a buffer against the first 15% of Underlying ETF losses, over the period from September 1, 2026 to August 31, 2027. The fund invests under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in investments that provide exposure to the Invesco QQQ Trust SM, Series 1 (the “Underlying ETF”). FLEX Options are exchange-traded option contracts with uniquely customizable terms. The fund is non-diversified.
Real Time Patterns 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.